- Home
- HSTM vs AGMB Comparison
HSTM vs AGMB Comparison
Compare HSTM & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSTM | AGMB |
|---|---|---|
| Founded | 1990 | 2017 |
| Country | United States | Belgium |
| Employees | N/A | 62 |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 700.0M | 562.4M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | HSTM | AGMB |
|---|---|---|
| Price | $25.81 | $11.18 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $28.00 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 192.4K | 76.7K |
| Earning Date | 05-04-2026 | 04-23-2026 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $304,064,000.00 | N/A |
| Revenue This Year | $9.45 | N/A |
| Revenue Next Year | $5.12 | $17.86 |
| P/E Ratio | $130.05 | ★ N/A |
| Revenue Growth | ★ 4.26 | N/A |
| 52 Week Low | $19.50 | $8.75 |
| 52 Week High | $29.59 | $17.45 |
Technical Indicators
Market Signals| Indicator | HSTM | AGMB |
|---|---|---|
| Relative Strength Index (RSI) | 61.48 | 54.32 |
| Support Level | $25.00 | $9.54 |
| Resistance Level | $26.01 | $12.53 |
| Average True Range (ATR) | 0.77 | 1.10 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 62.60 | 59.06 |
Price Performance
Historical ComparisonAbout HSTM HealthStream Inc.
HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care. The company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs. It also provides its solutions to nursing schools and nursing students.
About AGMB AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.